Central Pontine Myelinolysis

No Results

No Results

processing….

Adams et al described central pontine myelinolysis (CPM) as a unique clinical entity. They published their findings in 1958, observing that patients who suffered from alcoholism or malnutrition developed spastic quadriplegia, pseudobulbar palsy, and varying degrees of encephalopathy or coma from acute, noninflammatory demyelination that centered within the basis pontis. ^[1]

Physicians currently recognize that central pontine myelinolysis occurs inconsistently as a complication of severe and prolonged hyponatremia, particularly when corrected too rapidly. ^[2] Standard of care requires judicious treatment of electrolyte disturbances to reduce the incidence of osmotic myelinolysis. ^[3]

Central pontine myelinolysis is a concentrated, frequently symmetric, noninflammatory demyelination within the central basis pontis. In at least 10% of patients with central pontine myelinolysis, demyelination also occurs in extrapontine regions, including the mid brain, thalamus, basal nuclei, and cerebellum. The exact mechanism that strips the myelin sheath is unknown.

One theory proposes that in regions of compact interdigitation of white and gray matter, cellular edema, which is caused by fluctuating osmotic forces, results in compression of fiber tracts and induces demyelination. Prolonged hyponatremia followed by rapid sodium correction results in edema. During the period of hyponatremia, the concentration of intracellular charged protein moieties is altered; reversal cannot parallel a rapid correction of electrolyte status. The term osmotic myelinolysis is more appropriate than central pontine myelinolysis for demyelination occurring in extrapontine regions after the correction of hyponatremia. ^{[4, 5, 6, 7]}

Conditions predisposing patients to central pontine myelinolysis include alcoholism, liver disease, malnutrition, and hyponatremia.

Risk factors for central pontine myelinolysis in the hyponatremic patient include the following:

Serum sodium of less than 120 mEq/L for more than 48 hours

Aggressive IV fluid therapy with hypertonic saline solutions

Development of hypernatremia during treatment

Many patients who have hyponatremia that is corrected rapidly do not develop central pontine myelinolysis. Thus, other less obvious risk factors probably exist. Central pontine myelinolysis reportedly occurs occasionally in patients who are treated for hypernatremia.

Central pontine myelinolysis may complicate liver transplantation surgery. ^[8] Consider central pontine myelinolysis when confusion and/or weakness complicate the liver transplant patient’s postoperative recovery. The author provided consultation for a liver transplant patient who developed central pontine myelinolysis and critical illness neuromyopathy. The typical exam findings for central pontine myelinolysis were masked by peripheral nerve and muscle disease. MRI studies provided conclusive evidence for brain stem demyelination.

Burn patients with a prolonged period of serum hyperosmolality are prone to developing central pontine myelinolysis. Central pontine myelinolysis also has occurred concurrently with Wilson disease and neoplasia.

The exact incidence of central pontine myelinolysis is unknown. A study by Singh et al demonstrated that central pontine myelinolysis was present in 29% of postmortem examinations of liver transplant patients. Two thirds of these patients had serum sodium fluctuations of only ± 15-20 mEq/L. ^[9] Central pontine myelinolysis occurs more frequently in females than in males.

Death is common. Maximum recovery from central pontine myelinolysis may require several months. Chronic neurologic deficits range from locked-in syndrome to spastic quadriparesis. Patients with extrapontine lesions may exhibit tremor and ataxia.

Possible complications include those associated with severe central nervous system injury and reduced activity, such as the following:

Ventilator dependency

Aspiration pneumonia

Venous thrombosis

Pulmonary embolism

Contractures

Muscle wasting

Decubitus ulcers

Urinary tract infections

Depression

Severe hyponatremia is diagnosed in a person who presents to the emergency department with delirium. Electrolyte disturbances frequently cause encephalopathy. IV fluid therapy is administered, and serum sodium is normal by the next day. The patient’s mental status improves, and he or she is more alert, but this is followed by neurologic deterioration 48-72 hours later.

Key features of the neurologic exam include confusion, horizontal gaze paralysis, and spastic quadriplegia. Increased limb tone, limb weakness, hyperactive reflexes, and Babinski sign are typical features of spastic quadriplegia or lesions that involve upper motor neurons or the corticospinal tracts. Brain MRI reveals intense symmetric demyelination in the brain stem pons. ^{[10, 11]}

The most consistent examination findings are those of pseudobulbar palsy and spastic quadriplegia caused by demyelination of corticospinal and corticobulbar tracts within the pons. The volume of demyelination within the pons is variable. ^[12] The loss of myelin can occur in adjacent brainstem areas and in more distal supratentorial locations. Thus, a diverse spectrum of examination findings and long-term disabilities are found.

Pseudobulbar palsy is characterized by head and neck weakness, dysphagia, and dysarthria. Lesions within the pons cause horizontal gaze paralysis. Vertical ophthalmoparesis is caused by demyelination extending through the mid brain.

Delirium is extremely common. Coma or delirium results from lesions in the pontine tegmentum and/or thalamus. Abnormalities in sensory modalities usually are not observed.

A large basis pontis lesion may cause a locked-in syndrome, which includes paralysis of lower cranial nerves and limb musculature. Vertical eye movements, blinking, breathing, and alertness may remain intact in these patients.

Cerebral spinal fluid (CSF) probably is not necessary when the etiology and diagnosis are obvious. CSF studies may demonstrate increased opening pressure, elevated protein, or mononuclear pleocytosis.

MRI is the imaging modality of choice (see the image below). According to one study, serial brain imaging is of value because a substantial proportion of patients have normal findings on initial MRI. ^[13] Typically, T2-weighted MRI images demonstrate hyperintense or bright areas where demyelination has occurred and has been caused by relatively increased water content in those regions. MRI or CT imaging of the brain stem may not reveal an obvious anatomic disturbance. A thorough neurologic exam therefore is indispensable. ^[14]

Electroencephalography in central pontine myelinolysis may demonstrate diffuse bihemispheric slowing. Brainstem-evoked potentials may reveal abnormalities when neuroimaging is unrevealing.

Relative preservation of axons and surrounding neurons within areas of demyelination and an associated reduction in oligodendroglia is present.

Treatment is supportive only. Correction rate is controversial (for more information on treatment, see the Medscape Reference article on hyponatremia). Diligently avoid hypernatremia. It is advised to study details concerning the etiology and correction of electrolyte disorders.

Patients with alcoholism should receive vitamin supplementation. Formally evaluate their nutritional status.

Once medically stable, the patient should be evaluated by a neurorehabilitation specialist and, if appropriate, transferred for further inpatient recovery-oriented therapy.

Patients who survive central pontine myelinolysis likely require extensive and prolonged neurorehabilitation. Incorporate occupational, physical, speech, and language therapists early in the care of such patients. Swallowing studies are necessary to evaluate for dysphagia and determine the risk for aspiration pneumonia.

Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959 Feb. 81(2):154-72. [Medline].

Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol. 2014 Dec. 21 (12):1443-50. [Medline].

Kumar S, Fowler M, Gonzalez-Toledo E, Jaffe SL. Central pontine myelinolysis, an update. Neurol Res. 2006 Apr. 28(3):360-6. [Medline].

Haspolat S, Duman O, Senol U, Yegin O. Extrapontine myelinolysis in infancy: report of a case. J Child Neurol. 2004 Nov. 19(11):913-5. [Medline].

Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore). 1993 Nov. 72(6):359-73. [Medline].

Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med. 1997 Jan 1. 126(1):57-62. [Medline].

Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004 Sep. 75 Suppl 3:iii22-8. [Medline].

Crivellin C, Cagnin A, Manara R, Boccagni P, Cillo U, Feltracco P, et al. Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study. Transplantation. 2015 Jun. 99 (6):1257-64. [Medline].

Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore). 1994 Mar. 73(2):110-8. [Medline].

Sharma P, Sharma S, Panwar N, Mahto D, Kumar P, Kumar A, et al. Central Pontine Myelinolysis Presenting With Tremor in a Child With Celiac Disease. J Child Neurol. 2013 Feb 5. [Medline].

Walterfang M, Goh A, Mocellin R, Evans A, Velakoulis D. Peduncular hallucinosis secondary to central pontine myelinolysis. Psychiatry Clin Neurosci. 2012 Dec. 66(7):618-21. [Medline].

Min Y, Park SH, Hwang SB. Corticospinal tract and pontocerebellar fiber of central pontine myelinolysis. Ann Rehabil Med. 2012 Dec. 36(6):887-92. [Medline]. [Full Text].

Graff-Radford J, Fugate JE, Kaufmann TJ, Mandrekar JN, Rabinstein AA. Clinical and radiologic correlations of central pontine myelinolysis syndrome. Mayo Clin Proc. 2011 Nov. 86(11):1063-7. [Medline]. [Full Text].

DeWitt LD, Buonanno FS, Kistler JP, et al. Central pontine myelinolysis: demonstration by nuclear magnetic resonance. Neurology. 1984 May. 34(5):570-6. [Medline].

Christopher Luzzio, MD Clinical Assistant Professor, Department of Neurology, University of Wisconsin at Madison School of Medicine and Public Health

Christopher Luzzio, MD is a member of the following medical societies: American Academy of Neurology

Disclosure: Nothing to disclose.

Stephen A Berman, MD, PhD, MBA Professor of Neurology, University of Central Florida College of Medicine

Stephen A Berman, MD, PhD, MBA is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, Phi Beta Kappa

Disclosure: Nothing to disclose.

Howard A Crystal, MD Professor, Departments of Neurology and Pathology, State University of New York Downstate; Consulting Staff, Department of Neurology, University Hospital and Kings County Hospital Center

Howard A Crystal, MD is a member of the following medical societies: American Academy of Neurology and American Neurological Association

Disclosure: Accera Pharmaceuticals Honoraria Consulting

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

Central Pontine Myelinolysis

Research & References of Central Pontine Myelinolysis|A&C Accounting And Tax Services
Source

Share on Facebook

Tweet

Follow us